Unknown NA INTERVENTIONAL 1-arm NCT03606850

Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study (EXCIPSY)

Pilot Study on the Identification of Cortical Excitability Changes Measured by Transcranial Magnetic Stimulation (TMS) as Markers of Antidepressant Response

Sponsor: Centre Hospitalier du Rouvray

Conditions Major Depressive Disorder

Interventions Measurements of markers of cortical excitability by TMS

Updated 5 times since 2018 Last updated: Jul 28, 2018 Started: Jul 30, 2018 Primary completion: Aug 30, 2020 Completion: Aug 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Major Depressive Disorder, this trial is ongoing. The trial is conducted by Centre Hospitalier du Rouvray and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Aug 2018 — Sep 2020 [monthly]

Recruiting NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier du Rouvray
Centre hospitalier de Ville-Evrard, France
University Hospital Caen, France

Data source: Centre Hospitalier du Rouvray

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sotteville-lès-Rouen, France